Manuel Villareal, MD
Allergy & Immunology · Lakeside Park, KYNPI 1255389409
Payments from drug & device makers
Across 406 payments — averaging $1313.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$160K
- Merck$112K
- Hikma Pharmaceuticals USA$64K
- Novartis$53K
- Astrazeneca AB$41K
- Shionogi Inc$39K
- plus $65K from 28 others
What the payments were for
- Travel & lodging$5948%
- Food & beverage$6,76691%
- Education$801%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 45 | $159,533 |
| Merck | 42 | $111,506 |
| Hikma Pharmaceuticals USA | 11 | $63,802 |
| Novartis | 11 | $52,695 |
| Astrazeneca AB | 4 | $41,113 |
| Shionogi Inc | 16 | $39,062 |
| Cipla USA Inc. | 18 | $34,266 |
| GSK | 71 | $17,251 |
| Sanofi US Services Inc. | 6 | $9,276 |
| Sanofi | 25 | $895 |
| Regeneron Healthcare Solutions, Inc. | 13 | $535 |
| Optinose US, Inc. | 18 | $370 |
| Pfizer | 18 | $345 |
| CSL Behring | 18 | $328 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $289 |
| Teva Pharmaceuticals USA, Inc. | 17 | $284 |
| Covis Pharma GmbH | 12 | $222 |
| Grifols USA, LLC | 12 | $204 |
| Octapharma USA, Inc. | 3 | $150 |
| Alk-abello, Inc | 7 | $142 |
| Urovant Sciences Inc | 1 | $125 |
| Stryker | 1 | $125 |
| Kaleo, Inc. | 7 | $106 |
| AbbVie | 1 | $85 |
| Amgen | 4 | $84 |
| Sanofi-aventis U.S. LLC | 1 | $68 |
| Blueprint Medicines Corporation | 2 | $56 |
| Biocryst US Sales Co., LLC | 2 | $51 |
| Shire North American Group Inc | 3 | $50 |
| Genentech USA, Inc. | 2 | $47 |
| Mylan Specialty L.p. | 1 | $22 |
| Hospira, Inc. | 1 | $16 |
| Pharming Healthcare, Inc. | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$533,133 in reported general payments places this provider in the 95th percentile of 66 allergy & immunology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 15 | $66,969 |
| Dupixent PenDupilumab | 11 | $40,999 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 31 | $27,322 |
| Advair HfaFluticasone Propion/Salmeterol | 52 | $23,113 |
| Breo ElliptaFluticasone/Vilanterol | 22 | $14,096 |
| Arnuity ElliptaFluticasone Furoate | 46 | $13,633 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 16 | $13,192 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 64 | $9,284 |
| Epinephrine | 39 | $8,756 |
| SymbicortBudesonide/Formoterol Fumarate | 22 | $7,695 |
| Azelastine Hcl | 179 | $4,455 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 27 | $3,196 |
| Fluticasone Propionate | 132 | $2,373 |
| Mometasone Furoate | 46 | $1,990 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 63 | $1,802 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $17,251 | $55,05199 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $159,533 | $20,88638 claims |
| Hikma Pharmaceuticals USAEpinephrine | $63,802 | $8,75639 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 66 allergy & immunology providers in Kentucky.
Other allergy & immunology in Lakeside Park
- Lee CloreOwensboro$3.7M
- William GreisnerLexington$1.8M
- James SublettLouisville$1.7M
- James SublettLouisville$481K
- Stephen PollardLouisville$463K
- Hans OttoFlorence$381K
- Douglas LotzLouisville$199K
- Timothy FranxmanLouisville$162K
- Jeremy JonesLouisville$149K
- Rajiv AroraLexington$144K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.